Is Cue Biopharma, Inc. CUE stock halal to invest in?

No, as of February 2026, Cue Biopharma, Inc. stock (CUE) is currently categorized as NOT Shariah Compliant. The company's status is determined by a rigorous financial screening process, which uses the criteria set by the AAOIFI (Accounting and Auditing Organization for Islamic Financial Institutions) as the primary global standard for Islamic investing. Cue Biopharma, Inc. has been assessed to have exceeded the permissible financial thresholds—specifically in areas like interest-bearing debt or non-permissible income (such as income from interest)—and, therefore, does not qualify as a halal investment under the current review. For investors seeking Shariah compliant global stocks, it is essential to check the latest compliance status, as these screenings are updated regularly (e.g., monthly) or upon the release of new financial reports. You can find the most current status for Cue Biopharma, Inc. and alternative halal stock options within the Tabadulat app.

How often is Cue Biopharma, Inc. CUE reviewed for Shariah compliance?

At Tabadulat, we receive Shariah compliance data on Cue Biopharma, Inc. CUE monthly. We apply the rigorous AAOIFI screening methodology under the direct supervision of our dedicated Shariah Supervisory Board to ensure your investments are consistently compliant.

Does Cue Biopharma, Inc. CUE pass the AAOIFI Non Permissible Income criteria?

No, as of February 2026, Cue Biopharma, Inc. stock (CUE) does not pass the AAOIFI Non Permissible Income criterion. The company's income from non-permissible sources has exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does Cue Biopharma, Inc. CUE pass the AAOIFI Interest Bearing Investments criteria?

No, as of February 2026, Cue Biopharma, Inc. stock (CUE) does not pass the AAOIFI Interest Bearing Investments criterion. The company's interest-bearing investments have exceeded the permissible threshold set by AAOIFI, indicating the stock is currently not Shariah compliant for this screen.

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

Yes, as of February 2026, Cue Biopharma, Inc. stock (CUE) passes the AAOIFI Interest Bearing Debt criterion. The company's interest-bearing debt is below the acceptable threshold set by AAOIFI.

English

العربية

Be the First to Know!

Join our waitlist for exclusive early access to Tabadulat’s Shariah-compliant trading platform. Get notified as soon as we go live and start investing with confidence.

Cue Biopharma, Inc.

NASDAQ

Shariah-Compliant

Not Shariah

CUE

About

Cue Biopharma, Inc.

CUE

Cue Biopharma Inc. is a biotechnology company focused on developing innovative biologic drugs that can precisely modulate the human immune system. The company's primary purpose is to create therapies that can selectively enhance or inhibit immune responses, potentially leading to treatments for a wide array of diseases, including cancer and autoimmune disorders. A notable feature of Cue Biopharma is its proprietary drug development platform, Immuno-STAT, designed to target specific T cells in the immune system, thereby refining the activation or suppression of immune processes. This targeted approach could impact several sectors, particularly oncology and immunotherapy, by offering more targeted and potentially effective treatment options. Founded in 2014 and based in Massachusetts, Cue Biopharma is a key player in the biotechnology industry, contributing to the growing body of research and development in precision medicine. Its work has significant market implications, as the demand for personalized medicine and immunotherapies continues to rise, reflecting broader trends in healthcare innovation and therapeutic development.

Sector:

Healthcare

Industry:

Biotechnology

Employees:

Website:

https://www.cuebiopharma.com

CUE

Frequently asked questions

Related stocks

Mobile login screen for Tabadulat with fields to enter email, a Continue button, an option to create an account, and a language selector showing EN.

Step 1

Sign Up.

Begin by creating your Tabadulat account. Simply enter your details and complete the verification process. You’ll be up and running in no time.

Mobile screen showing add money interface with 100 AED amount and Manual Bank Transfer payment method selected, noting 1-2 business days processing.

Step 2

Deposit.

Add funds to your account using a secure payment method. You can deposit in multiple currencies to get started.

Step 3

Screen.

Screen Stocks for Free and explore a wide range of stocks that are ethically screened for Shariah compliance. Use our Halal Stock Screener to find the best opportunities.

Step 4

Trade.

Once you’ve chosen the right stocks, simply place your trades. Our platform offers real-time market data and seamless execution.

Mobile screen showing investment portfolio with $100,000 total value, $48,000 invested, and a $2,000 return (4.50%) with a line graph and options for 1W, 1M, 3M, YTD, 1Y, Max, plus Trade and Deposit buttons.

Step 5

Track.

Track your Portfolio and monitor your investments with our easy-to-use dashboard. View your portfolio performance, manage assets, and make adjustments as needed.

Step 6

Withdraw.

When you're ready, withdraw your funds quickly and securely to your bank account.

Cue Biopharma, Inc.

About

Cue Biopharma, Inc.

CUE

Frequently asked questions

Is Cue Biopharma, Inc. CUE stock halal to invest in?

How often is Cue Biopharma, Inc. CUE reviewed for Shariah compliance?

Does Cue Biopharma, Inc. CUE pass the AAOIFI Non Permissible Income criteria?

Does Cue Biopharma, Inc. CUE pass the AAOIFI Interest Bearing Investments criteria?

Does STOCK pass the AAOIFI Interest Bearing Debt criteria?

How do I buy Cue Biopharma, Inc. CUE stock?

Sign Up.

Deposit.

Screen.

Trade.

Track.

Withdraw.